pura-associated IgA nephropathy. However, the macrophages in the glomeruli of patients with IgA Background. Henoch-Schö nlein purpura is a common vasculitis of childhood affecting the skin, joints, gastro-nephropathy and interstitial macrophages from both studied groups, i.e. without and with IgA nephropathy, intestinal tract, and kidney. The mesangial deposition of IgA1 is the most critical factor for the prognosis of harbour capacity to recognize carrier-immobilized a-N-acetylgalactosamine. Access to this binding site for patients with this disease. The aberrant glycosylation of the IgA1 subclass with the absence of terminally the neoligand conjugate can be blocked by the monoclonal antibody MEM-18 recognizing CD14 antigen. located galactose and presence of only a-N-acetylgalactosamine in O-linked oligosaccharides in the hinge Conclusion. The possibility for a participation of macrophage deposition of IgA1 in mesangium via a region of IgA1 represents a prominent difference from the normal IgA1. These alterations prompt the supposi-lectin mechanism involving this binding capacity warrants further studies. tion that the sugar part may guide IgA deposition by recognition of endogenous lectins on the mesangium. Methods. Owing to the limited knowledge about the Key words: a-N-acetylgalactosamine; CD14; HenochSchö nlein purpura; IgA nephropathy; lectin macroexpression of carbohydrate-binding sites in the human kidney we initiated the study of this aspect with a class phage of tools which are suitable to map the lectinome of cells. Employing biotinylated neoglycoconjugates, glycosaminoglycans, and sulphated polysaccharides we
Introduction
monitored the presence of accessible carbohydratebinding sites in control kidneys represented by tumourfree areas of kidneys with Grawitz tumour and in Henoch-Schö nlein purpura (HSP) is the most biopsies from patients with Henoch-Schö nlein pur-common vasculitis of childhood, affecting the skin, pura-associated IgA nephropathy.
joints, gastrointestinal tract, and kidneys. Kidney Results. Using frozen sections, no expression of any involvement is the most serious and limiting factor in tested carbohydrate-binding site(s) was observed in the the clinical outcome of children with HSP. Despite the endothelial and the mesangial cells in glomeruli of the fact that the disease has been known for more than control kidneys as well as in the biopsies from 150 years [1] its aetiology still remains ill defined. Henoch-Schö nlein purpura IgA nephropathic kidneys, Histopathological examinations in the kidney have in contrast to the tubules. The N-acetylgalactosamine-revealed mesangial proliferation accompanied by the binding sites were expressed only in the inner layer of predominantly mesangial deposition of IgA. An almost Bowman's capsule of 20% of glomeruli of the control identical picture of glomerular pathology is seen in kidney from one patient with Grawitz tumour and one IgA nephropathy [2, 3] . The actual mechanism of IgA biopsy from a patient with Henoch-Schö nlein pur-deposition in the kidneys is unknown. Deposited IgA is of the polyclonal IgA1 subclass characterized by a high proportion of l light chains, which has an importCorrespondence and offprint requests to: Anna Š edivá, Institute of ant source in plasma cells located in the bone marrow IgA immunoglobulin (Sevac, Prague, Czech Republic).
cytes harvested from patients with IgA nephropathy Human galectin-3 (Gal-3) was detected by the anti-human produce IgA that directly interacts with mesangium in it is known that the proportion of sialylated IgA1 is galactan at a concentration of 20 mg/ml (TBS with 5 mM of lower in patients with IgA nephropathy than in con-Ca2+) was used for the visualization of carbohydrate-binding trols [15] . The IgA1 molecules with altered glycosy-sites ( Table 1) [24] [25] [26] [27] [28] [29] [30] [31] . The specificities of probes used are lation form aggregates and bind to the surface of the shown in Table 1 
To evaluate this hypothesis, it is essential to have
The control sections were incubated with competitive information available on the capacity of different com-inhibitors for ascertaining the sugar specificity of reaction partments in the human kidney to bind carbohydrate and with second-step reagents only to exclude signal generaligands. Since the monitoring of the expression of tion by the binding of the mannose-rich glycoproteins avidin carbohydrate-binding site(s) in the human kidney has and horseradish peroxidase as constituents of the kit to so far not been performed, the presented study focused endogenous mannose receptors [32] . Some sections were on the question whether suitable carbohydrate ligands counterstained by haematoxylin and all specimens were routinely dehydrated by alcohol and mounted in Solacryl can bind to the mesangium of human kidney. This The results of glycohistochemical reactions do not pathy and tumour-free sections of kidneys from five patients appear to be substantially influenced by the fixation with tumours. Frozen sections (7-10 mm thick) were used procedure used and independent on the labelling profor glycohistochemical analysis after fixation with absolute cedure, i.e. using the fluorescently and peroxidasemethanol (4°C ), absolute acetone (4°C ), or 2% (w/v) parlabelled second-step reagents. A high level of cytoaformaldehyde in PBS (4°C, pH 7.2) for 5 min. The IgA deposits were visualized by FITC-labelled swine-anti human plasmic expression of carbohydrate-binding sites in Table 1 . Probes used for reverse lectin histochemical detection of carbohydrate-binding sites
Specificity
Probe Abbreviation a--mannoside a--mannose-BSA-biot Man a--mannose-6-P a--mannose-6-P-BSA-biot mesangial deposition. The double-labelling experiments revealed that these macrophages were strongly positive for IgA ( Figure 1) . Interestingly, these macrocells of renal tubules of all types was found in kidney phages expressed galectin-3, a known binding partner with and without HSP-associated IgA nephropathy for IgE and IgM. (Figures 1 and 2) . However, no binding of tested probes was detected on the surface or in the cytoplasm of endothelial and mesangial cells of studied glomeruli Discussion in samples from both the studied groups of patients under these conditions (Figure 1 ). The only exception in this respect was the inner layer of the Bowman's The precise delineation of the aetiology of both Henoch-Schö nlein purpura and IgA nephropathy concapsule, where binding sites for a( b)-GalNAc were seen in approximately 20% of glomeruli from one tinues to warrant in these efforts despite evident pro- gress [2, 3] . A major question concerns the definition examined features will explain this distinct behaviour of the IgA1, it is remunerative to try and correlate of the causative agent for IgA nephropathy. Due to this manifestation of IgA1 deposits the biochemical defined biochemical features of the altered IgA1 to putative molecular mechanism(s) how IgA1 may accucharacteristics of IgA (isotype, light chain, origin, charge, glycosylation, elevated levels) have been care-mulate in this site. An aberrant glycosylation of IgA1 molecules has repeatedly been observed in the given fully studied. Since it is probable that one or several line of reasoning. This feature may entail the reaction tissue sections. Since the reported abnormalities in the glycosylation of IgA molecule include its decreased crucial for pathogenesis of the disease. Besides acting as a spatial factor in guiding the folding of a nascent sialylation and galactosylation, particularly lacking terminal galactose and thus exposing a-GalNAc, we glycoprotein, the carbohydrate chains themselves may harbour ligand properties for endogenous lectins have employed a panel of probes including a( b)-GalNAc. We found binding sites for a( b)-GalNAc in adding to the potential of the peptide part to be engaged in recognitive interactions [33] . Indeed, this approximately 20% of glomeruli of one patient with Grawitz tumour as well as in a biopsy from one patient concept of glycan functionality is being exploited to target drugs by tailor-made carbohydrate ligands as with IgA nephropathy. These detectable binding sites were not located in mesangium, which is the common part of neoglycoconjugates [18, 34, 35] .
To test this hypothesis in our context experimentally, site of IgA deposition, but in the inner layer of Bowman's capsule. carrier-immobilized carbohydrate structures or natural glycoconjugates offer a suitable class of tools. They
Concerning the nature of the probe, it should not be overlooked that it mimics the terminal (sugar) part allow monitoring of the presence of accessible sites in
